Clinical trials
Observational Urinary Bladder Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Al-Azhar University | 1 |
| Assaf-Harofeh Medical Center | 1 |
| Astellas Pharma Europe Ltd. | 1 |
| Astellas Scientific & Medical Affairs, Inc. | 1 |
| Connecticut Children's Medical Center | 1 |
| Consorci Sanitari de Terrassa | 1 |
| Copenhagen University Hospital at Herlev | 1 |
| Corporacion Parc Tauli | 1 |
| IRCCS San Raffaele | 1 |
| Institut Bergonié | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Diseases | 16 |
| Urinary Bladder Neoplasms | 5 |
| Urologic Diseases | 4 |
| Cystitis, Interstitial | 2 |
| Neoplasms | 2 |
| Non-Muscle Invasive Bladder Neoplasms | 2 |
| Urinary Bladder, Overactive | 2 |
| Urinary Tract Infections | 2 |
| Acidosis | 1 |
| Bacterial Infections | 1 |
Trials
Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.